HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Intra-arterial chemoembolization of non-resectable hepatocellular carcinoma].

Abstract
During a period of nine months, fifteen patients with extensive hepato-cellular carcinomas were subjected to palliative arterial chemo-embolisation using doxorubicin and cisplatin in an emulsion with Lipiodol and/or Spherex particles. Two patients (stage Child C) died within two weeks as the result of liver failure. The remaining thirteen patients showed improvement in their general condition. Subsequent CT showed evidence of tumour reduction and reduction of ascites. Gas production in the tumour was considered as evidence of tumour necrosis. Biochemical results confirmed these findings with a fall of AFP as tumour marker indicating tumour regression.
AuthorsA Scholz, M Langer, R Langer, R Felix, P Neuhaus
JournalRoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin (Rofo) Vol. 154 Issue 3 Pg. 258-61 (Mar 1991) ISSN: 1438-9029 [Print] Germany
Vernacular TitleIntraarterielle Chemoembolisation nicht-resektabler hepatozellulärer Karzinome.
PMID1707177 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Iodized Oil
  • Doxorubicin
  • Cisplatin
Topics
  • Aged
  • Carcinoma, Hepatocellular (drug therapy, therapy)
  • Cisplatin (administration & dosage)
  • Combined Modality Therapy
  • Doxorubicin (administration & dosage)
  • Embolization, Therapeutic
  • Female
  • Humans
  • Iodized Oil (administration & dosage)
  • Liver Neoplasms (drug therapy, therapy)
  • Male
  • Middle Aged
  • Palliative Care

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: